---
$id: https://graph.org.ai/products/commodity/51384614
$type: Product
source: UNSPSC
code: "51384614"
title: "Mofebutazone"
class: "51384600"
classTitle: "Nonsteroidal anti inflammatory pyrazoles"
family: "51380000"
familyTitle: "Nonsteroidal anti inflammatory drugs NSAIDs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Mofebutazone

**UNSPSC Code**: 51384614
**Class**: [Nonsteroidal anti inflammatory pyrazoles](Nonsteroidal anti inflammatory pyrazoles.mdx)
**Family**: [Nonsteroidal anti inflammatory drugs NSAIDs](../Nonsteroidal anti inflammatory drugs NSAIDs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C13H16N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SPW36WUI5Z, chemically known as 3,5-pyrazolidinedione, 4-butyl-1-phenyl- but generally known as mofebutazone, which bears US NIH Compound Identifier 16639. European Medicines Agency schedules Mofebutazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09033MIG. The term MOFEBUTAZONE is an International Non-Proprietary Name. World Health Organization schedules mofebutazone in its Anatomical Therapeutic Chemical (ATC) Classification. MOFEBUTAZONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule mofebutazone under HS 29331990 and SITC 51571. As of Q4 2014, MOFEBUTAZONE remains the US FDA Preferred Term for this commodity. Mofebutazone bears US NLM identifiers UMLS ID C0066774 and NCI Concept Code C73089. SMILES: O=C1N(NC(=O)C1CCCC)C1CCCCC1.

